What can you expect
-
Learn and gain detailed insights into Monolith X, Andromeda X, and Prometheus Panta.
-
Experience these technologies first-hand by testing samples during the hands-on session.
-
Discuss your own projects with experts and discover how scientists in your area have implemented the technologies successfully in their research.
-
09:30
Introduction from Merck KGaA<br><i>Dr. Ansgar Wegener & Dr. Nina Grossmann, Merck Healthcare KGaA</i>
-
09:40
Introduction from NanoTemper Technologies<br><i>Dr. Gianluca Russo, Account Manager, NanoTemper Technologies</i>
-
09:50
Unraveling Protein Stability: A Journey from Expression to Advanced Biophysical Analysis Using Andromeda X and Prometheus Panta<br><i>Dr. Ping Zhang, Field Application Scientist, NanoTemper Technologies</i>
-
10:25
From Screening to Validation: Exploring Biomolecular Interactions with Spectral Shift Technology<br><i>Dr. Gianluca Russo, Account Manager, NanoTemper Technologies</i>
-
11:00
Coffee Break
-
11:30
Utilization of Nano Differential Scanning Fluorimetry as an Efficient Tool for Routine Thermal Stability Assessment of Monoclonal Antibodies and Antibody-Drug Conjugates<br><i>Dr. Jason Tonillo, Lab Head of ADC Analytics, ADCs & Targeted NBE Therapeutics, Merck Healthcare KGaA</i>
-
12:00
Characterization of binary & ternary PROTAC complexes in solution using Monolith X<br><i>Dr. Fiona Sorrell, Lab Head, Structural Biology & Biophysics, Discovery Pharmacology, Merck Healthcare KGaA</i>
-
12:30
TBD<br><i>Dr. Can Araman, Senior Manager Protein Formulation Laboratory - Liquid Formulation R&D Life Science, Process Solutions, Upstream & Process Materials R&D, Merck Healthcare KGaA</i>
-
13:00
Lunch break<br><i>(optional)</i>
-
14:00
Measurements of samples for pre-registered attendees<br><i>(optional)</i>
Who should attend?
Anyone working in the field of biological research dealing with proteins and biomolecular interactions.